Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 1/20 | 0.35 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367536 | 1.00 | PSMD14 (0.35) | PSMD14COPS5POLBCYP1A2 | |
| SCHEMBL1402586 | 0.81 | CYP1A2 (0.36) | POLBCYP1A2 | |
| SCHEMBL812226 | 0.81 | — | — | |
| SCHEMBL577349 | 0.79 | PSMD14 (0.37) | PSMD14COPS5POLBCYP1A2 | |
| SCHEMBL2493490 | 0.77 | CYP1A2 (0.39) | PSMD14COPS5POLBCYP1A2 | |
| SCHEMBL28105930 | 0.77 | ACHE (0.33) | PSMD14COPS5 | |
| Ammonia Solution, Strong SCHEMBL10002546 | 0.77 | PSMD14 (0.35) | PSMD14COPS5POLBCYP1A2 | |
| SCHEMBL551215 | 0.77 | PSMD14 (0.35) | PSMD14COPS5POLBCYP1A2 | |
| SCHEMBL7076223 | 0.72 | POLB (0.39) | PSMD14COPS5POLB | |
| SCHEMBL28526421 | 0.72 | ALDH1A1 (0.43) | PSMD14COPS5CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017025244-A1 | COSMETIC PROCESS FOR TREATING KERATIN MATERIALS | L'OREAL (FR) | 2017-02-16 | — | — | WO | claimed |
| EP-0334051-B1 | Electron beam-curable composition for release material and process for preparation of release material | SHOWA DENKO KK (JP) | 1996-05-01 | — | — | EP | claimed |
| US-5206092-A | Irradiating a composition of polyolefin resin, dimethylsiloxane and a polyfunctional compound having unsaturation or thiol groups | SHOWA DENKO K.K. (JP) | 1993-04-27 | — | — | US | claimed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| JP-7215964-A | — | — | None | — | — | JP | disclosed |
| US-12606692-B2 | Spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2026-04-21 | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-3778170-B1 | METHOD FOR MANUFACTURING OPTICAL MEMBER | HOYA LENS THAILAND LTD (TH) | 2026-01-28 | — | — | EP | disclosed |
| US-20250376456-A1 | MONOMER FOR OPTICAL COMPONENT, POLYMERIZABLE COMPOSITION FOR OPTICAL COMPONENT, CURED PRODUCT, AND SPECTACLE LENS | HOYA LENS THAILAND LTD. (TH) | 2025-12-11 | — | — | US | disclosed |
| EP-4640735-A1 | CURABLE RESIN COMPOSITION AND PROCESSED PRODUCT OF SAME | ThreeBond Co., Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-0334051-A2 | Electron beam-curable composition for release material and process for preparation of release material | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1989-09-27 | — | — | EP | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329387-A2 | Plastic lens, and method for its preparation | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
| US-4766201-A | Hydroxy alkyl amide thio ether composition from bis-bicyclic amide acetal and polythiol | ASHLAND OIL INC. (US) | 1988-08-23 | — | — | US | disclosed |
| US-4737574-A | Poly(amide-thioether) containing thermoset polymeric composition from reaction of bisoxazoline with polythiol in the presence of certain cationic catalyst | ASHLAND OIL, INC. (US) | 1988-04-12 | — | — | US | disclosed |
| US-4696992-A | Thiol carbamates as latent accelerators for curing epoxy resins | ASHLAND OIL, INC. (US) | 1987-09-29 | — | — | US | disclosed |
| US-4665229-A | Preparation of hydroxy alkyl amide thio ether compounds from bicyclic amide acetal and thiol | ASHLAND OIL, INC. (US) | 1987-05-12 | — | — | US | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3974163-A | VULCANIZATION INHIBITOR | MONSANTO COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | PSMD14 745/4885COPS5 1135/4885POLB 2625/4885 |
| US-20250376456-A1 | MONOMER FOR OPTICAL COMPONENT, POLYMERIZABLE COMPOSITION FOR OPTICAL COMPONENT, CURED PRODUCT, AND SPECTACLE LENS | CRYZ, CRYAA, UACA | PSMD14 742/4885COPS5 1759/4885POLB 3740/4885 |
| US-12606692-B2 | Spectacle lens | POT1, TCOF1, CRY1 | PSMD14 916/4885COPS5 1968/4885POLB 2956/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | PSMD14 226/4885COPS5 4273/4885POLB 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.